EMA Consults on Virtual Control Groups

The European Medicines Agency (EMA) is consulting on using virtual control groups to reduce animal testing in medicines development. This initiative aims to advance ethical practices in pharmaceutical research while maintaining scientific rigor. For EU citizens, this could lead to more humane and potentially faster drug development processes, contributing to public health and animal welfare.

Read source